Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Interstitial fluid lipoproteins

Lundberg, Johannaa,b; Rudling, Matsa,b; Angelin, Boa,b

doi: 10.1097/MOL.0b013e3283630846
HYPERLIPIDAEMIA AND CARDIOVASCULAR DISEASE: Edited by Paul N. Durrington
Buy

Purpose of review The interstitium represents the fluid, proteins, solutes, and extracellular matrix comprising the microenvironment of tissues. We here review attempts to characterize the levels and composition of lipoproteins in human interstitial fluid, and identify potentially important questions for future research.

Recent findings Despite the high relevance of understanding how lipoproteins enter and exit the interstitial compartment, and how they interact with extracellular and cellular molecules, scientific progress in this field has been rather slow. This is partly due to methodological difficulties, both regarding how to obtain representative samples and how to perform appropriate measurements to compare patient cohorts and to evaluate responses to treatment. Predominant techniques include peripheral lymph cannulation and suction blister creation, both of which have inherent advantages and disadvantages. Detailed studies comparing the effects of long-term incubation of serum and lymph lipoproteins are compatible with the view that HDL in interstitial fluid takes up free cholesterol from cells and transfers it into the circulation.

Summary Studies of the concentration, composition, functionality, and turnover of interstitial fluid lipoproteins will be of great future interest for understanding how tissue cholesterol metabolism is regulated, and how different diseases link to increased risk for development of atherosclerosis.

aDepartment of Medicine, Metabolism Unit, Center for Endocrinology, Metabolism and Diabetes

bDepartment of Nutrition and Bioscience, Molecular Nutrition Unit, Center for Biosciences, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden

Correspondence to Bo Angelin, MD, PhD, Center for Endocrinology, Metabolism & Diabetes, C2 : 94, Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden. Tel: +4670 484 0115; fax: +468 711 0710; e-mail: bo.angelin@ki.se

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins